Spin offs

<p>Logo Nostrum Biodiscovery</p>

Nostrum Biodiscovery is a biotechnological company focused on the computational biology sector and, specifically, in the structure-based drug design area dedicated to early drug discovery and development based on rational design techniques.

Inbiomotion is a Barcelona-based personalized medicine company incorporated in 2011 with the goal of developing biomarkers that predict bone metastasis to improve the cancer patient’s quality of life.

Iproteos is a biotechnology company focused on the research and development of new therapeutic strategies based on peptidic protease inhibition. Iproteos is developing peptidic protease inhibitors for the treatment of CNS diseases.

IRB Barcelona Spin offs

Innovation projects

Innovation projects

<p>Institució Cerca</p>

The Premi Pioner seeks to recognize researchers at CERCA centres who, in the last 18 months, have defended a doctoral thesis that has a clear orientation towards launching or strengthening a technology or product of industrial or commercial interest or that can make a significant contribution to the development of public policies. In 2015, Benjamí Oller, former PhD student in Prof. Ernest Giralt’s lab, was awarded this prize for his thesis, entitled “From bee venom to blood-brain barrier shuttles. Development of minimized apamin derivatives for brain delivery of antibodies and other cargoes”.

More information on this news.

The type of high-risk/high-gain research at the frontiers of knowledge that the ERC promotes often generates unexpected or new opportunities for commercial and societal applications. The ERC is committed to ensure the full exploitation of the excellent, useful ideas it funds. The Proof of Concept funding helps ERC grant-holders bridge the gap between their research and the earliest stage of a marketable innovation.

 

VALUNI 2015 aims to encourage action plans of marketing units to promote technology commercialization via the licensing of patents and/or creation of technology-based companies. Furthermore, it seeks to strengthen technology projects and marketing activities in order to ensure effective technology transfer to the productive sector. The Innovation Department was granted this funding for the project INNOVal 2015.

 

News

<p>BIO-Europe Spring is the premier springtime partnering conference for the biotechnology industry. Image: BIOCAT, "Fundació BioRegió de Catalunya” (BioRegion of Catalonia Foundation).</p>
21 Mar 2017

On the occasion of the BIO-Europe Spring 2017 event in Barcelona, the newspaper “La Vanguardia” has published an article about the campaign to host the new headquarters of the London-based European

<p>IRB Barcelona's Innovation team strengthens ties with industry.</p>
20 Mar 2017

Today sees the start of the three-day international partnering conference BIO-Europe Spring 2017, with

<p>The image shows tumour cells infected by the virus, which expresses a fluorescent protein. Over the days (in the image fifth day), the virus multiplies, generating new virions that infect more cancer cells (IDIBAPS, IRB Barcelona)</p>
16 Mar 2017

Scientists at the IDIBAPS Biomedical Research Institute and at the Institute for Research in Biomedicine (IRB Barcelona) lead a study in which they have designed a new strategy to achieve genetical

<p>Scheme of therapeutic concept designed by IRB Barcelona. The protein frataxina binds to peptide shuttle (blue), allowing the protein to cross the blood brain barrier and reach the brain (IRB Barcelona)</p>
14 Mar 2017

The associations of patients and families Babel Family and the Asociación Granadina de l

Testimonial

Contact

Cristina Horcajada
Head of Innovation
Tel: +34 93 40 31193